Neoleukin Therapeutics Price History

Summary

NLTXDelisted Stock

USD 0.69 0.01 1.43%

If you're considering investing in Neoleukin Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neoleukin Therapeutics stands at 0.69, as last reported on the 19th of January, with the highest price reaching 0.71 and the lowest price hitting 0.67 during the day. We have found twenty-four technical indicators for Neoleukin Therapeutics, which you can use to evaluate the volatility of the firm. Please verify Neoleukin Therapeutics' Mean Deviation of 2.25, standard deviation of 3.7, and Risk Adjusted Performance of (0.03) to check out if the risk estimate we provide is consistent with the expected return of 0.0%.

Neoleukin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns
Cash	Small Risk	Average Risk	High Risk	Huge Risk
NLTX

Based on monthly moving average Neoleukin Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neoleukin Therapeutics by adding Neoleukin Therapeutics to a well-diversified portfolio.

Neoleukin Therapeutics Stock Price History Chart

There are several ways to analyze Neoleukin Stock price data. The simplest method is using a basic Neoleukin candlestick price chart, which shows Neoleukin Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Neoleukin Stock Price History Data

The price series of Neoleukin Therapeutics for the period between Mon, Oct 21, 2024 and Sun, Jan 19, 2025 has a statistical range of 0.27 with a coefficient of variation of 7.11. The daily prices for the period are spread out with arithmetic mean of 0.83. The median price for the last 90 days is 0.83. The company underwent 1:4 stock split on 19th of December 2023.

	Open	High	Low	Close	Volume
01/19/2025	0.70	0.71	0.67	0.69
07/24/2023	0.70	0.71	0.67	0.69	388,804
07/21/2023	0.72	0.74	0.69	0.70	997,276
07/20/2023	0.67	0.69	0.65	0.67	1,185,876
07/19/2023	0.73	0.75	0.65	0.66	1,247,610
07/18/2023	0.88	0.88	0.69	0.74	3,768,079
07/17/2023	0.88	0.94	0.86	0.93	168,822
07/14/2023	0.87	0.89	0.84	0.88	53,178
07/13/2023	0.84	0.87	0.84	0.86	179,398
07/12/2023	0.83	0.85	0.81	0.84	67,441
07/11/2023	0.83	0.85	0.81	0.85	44,506
07/10/2023	0.84	0.85	0.83	0.83	141,399
07/07/2023	0.82	0.85	0.82	0.84	41,492
07/06/2023	0.83	0.84	0.82	0.84	71,521
07/05/2023	0.84	0.85	0.83	0.83	38,858
07/03/2023	0.80	0.84	0.80	0.83	25,220
06/30/2023	0.83	0.84	0.82	0.83	33,579
06/29/2023	0.81	0.84	0.81	0.83	14,943
06/28/2023	0.81	0.82	0.79	0.81	37,111
06/27/2023	0.78	0.83	0.78	0.81	209,242
06/26/2023	0.77	0.80	0.76	0.79	275,610
06/23/2023	0.76	0.81	0.75	0.77	103,144
06/22/2023	0.77	0.79	0.75	0.76	49,700
06/21/2023	0.79	0.79	0.76	0.78	34,103
06/20/2023	0.76	0.80	0.75	0.79	39,414
06/16/2023	0.74	0.85	0.74	0.77	216,369
06/15/2023	0.75	0.75	0.74	0.74	46,047
06/14/2023	0.77	0.78	0.75	0.75	60,299
06/13/2023	0.78	0.80	0.77	0.77	68,678
06/12/2023	0.78	0.79	0.78	0.78	37,062
06/09/2023	0.79	0.80	0.78	0.78	54,537
06/08/2023	0.80	0.81	0.79	0.79	55,089
06/07/2023	0.82	0.82	0.79	0.80	32,300
06/06/2023	0.80	0.81	0.80	0.81	27,700
06/05/2023	0.81	0.83	0.80	0.81	110,689
06/02/2023	0.81	0.82	0.80	0.82	11,947
06/01/2023	0.81	0.82	0.80	0.82	61,295
05/31/2023	0.82	0.82	0.80	0.80	26,318
05/30/2023	0.80	0.84	0.79	0.82	92,921
05/26/2023	0.81	0.83	0.81	0.82	31,161
05/25/2023	0.86	0.90	0.80	0.81	134,716
05/24/2023	0.90	0.91	0.85	0.87	377,679
05/23/2023	0.90	0.90	0.85	0.88	95,400
05/22/2023	0.87	0.90	0.87	0.90	78,646
05/19/2023	0.88	0.89	0.86	0.87	40,043
05/18/2023	0.87	0.88	0.86	0.88	31,871
05/17/2023	0.88	0.88	0.86	0.87	40,876
05/16/2023	0.86	0.89	0.86	0.88	26,418
05/15/2023	0.87	0.89	0.86	0.87	118,097
05/12/2023	0.89	0.89	0.86	0.88	54,300
05/11/2023	0.88	0.89	0.86	0.88	33,421
05/10/2023	0.86	0.90	0.86	0.90	100,425
05/09/2023	0.87	0.90	0.86	0.89	181,987
05/08/2023	0.90	0.90	0.85	0.88	118,829
05/05/2023	0.89	0.90	0.87	0.90	100,194
05/04/2023	0.89	0.89	0.85	0.89	140,137
05/03/2023	0.89	0.90	0.84	0.88	302,274
05/02/2023	0.91	0.93	0.89	0.91	108,976
05/01/2023	0.89	0.92	0.87	0.90	315,925
04/28/2023	0.87	0.89	0.86	0.89	196,626
04/27/2023	0.85	0.88	0.83	0.87	205,040

About Neoleukin Therapeutics Stock history

Neoleukin Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neoleukin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neoleukin Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neoleukin Therapeutics stock prices may prove useful in developing a viable investing in Neoleukin Therapeutics

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington. Neoleukin Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 79 people.

Neoleukin Therapeutics Stock Technical Analysis

Neoleukin Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.

Volatility Indicators

View

Value Movement

View

A focus of Neoleukin Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neoleukin Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Comparator Now

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account

All Next

Launch Module

Neoleukin Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neoleukin Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Neoleukin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neoleukin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Consideration for investing in Neoleukin Stock

If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.

	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Global Correlations Find global opportunities by holding instruments from different markets
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

	Risk Adjusted Performance	(0.03)
	Jensen Alpha	(0.16)
	Total Risk Alpha	(0.27)
	Treynor Ratio	0.1994

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Neoleukin Therapeutics Price History

Sharpe Ratio = 0.0

Neoleukin Therapeutics Stock Price History Chart

Neoleukin Stock Price History Data

About Neoleukin Therapeutics Stock history

Neoleukin Therapeutics Stock Technical Analysis

Did you try this?

Run Portfolio Comparator Now

Portfolio Comparator

Neoleukin Therapeutics Technical and Predictive Indicators

Other Consideration for investing in Neoleukin Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY